Robigo and LEAPS, a subsidiary of Bayer, announced the completion of Series A financing to promote the development of engineered biologics. This type of product can guarantee crop yield and reduce costs.

Robigo and LEAPS, a subsidiary of Bayer, announced the completion of Series A financing to promote the development of engineered biologics. This type of product can guarantee crop yield and reduce costs.